Proposed staged rollout of Eli Lilly’s Mounjaro by NHS England includes digital solutions for wider access
The National Health Service (NHS) in England is exploring a phased introduction of the obesity treatment tirzepatide (Mounjaro, developed by Eli Lilly), driven by concerns over potentially high demand for the medication. The phased approach aims to ensure that individuals with the greatest clinical need receive the treatment first, while also preparing the system to meet the broader demand...Read More£1.2 million grant fuels development of AI platform for early arthritis detection
Henley Business School has secured a significant grant of £1.2 million to develop an innovative machine learning system aimed at improving the early detection and referral of rheumatic and musculoskeletal diseases (RMDs). The project, known as RMD-Health, seeks to transform the way these conditions are identified and managed, offering a pathway to quicker diagnoses and more effective...Read Moreby Nicholas FeenieOctober 7, 2024 Obesity and Population Health, Obesity in the UK, United States of America0 comments